Reneuron Group

ReNeuron is a leading, UK-based stem cell company. Our primary objective is the development of stem cell therapies targeting areas of significant unmet or poorly met medical need
Company Growth (employees)
Type
Public
HQ
Surrey Research Park, GB
Founded
1997
Size (employees)
44 (est)
Reneuron Group was founded in 1997 and is headquartered in Surrey Research Park, GB

Key People/Management at Reneuron Group

John Sinden

John Sinden

CSO

Reneuron Group Office Locations

Reneuron Group has an office in Surrey Research Park
Surrey Research Park, GB (HQ)
10 Nugent Rd

Reneuron Group Financials and Metrics

Reneuron Group Financials

Reneuron Group's revenue was reported to be £46 k in FY, 2017 which is a 59% increase from the previous period.
GBP

Revenue (FY, 2017)

46 k

Net income (FY, 2017)

(15.6 m)

EBITDA (FY, 2017)

(19.8 m)

EBIT (FY, 2017)

(19.9 m)

Market capitalization (31-Oct-2017)

55.4 m

Closing share price (31-Oct-2017)

0

Cash (31-Mar-2017)

28.1 m
Reneuron Group's current market capitalization is £55.4 m.
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

27 k93 k31 k29 k40 k17 k2230 k29 k46 k

Revenue growth, %

36%(3%)

Operating expense total

6.9 m4.8 m6.2 m6.9 m7.1 m8 k10.4 m13.8 m19.9 m

EBITDA

(6.7 m)(4.5 m)(3.9 m)(6.7 m)(7 m)(7.9 k)(10.3 m)(13.7 m)(19.8 m)
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

2.8 m943 k5.5 m9.7 m4 m3.5 m14.9 k12.4 m17.4 m28.1 m

Accounts Receivable

386

Current Assets

3.2 m2 m6.2 m10.5 m5.1 m4.6 m22.3 k14.1 m64.9 m58.1 m

PP&E

1 m834 k541 k419 k298 k213 k225161 k361 k724 k
    GBPY, 2017

    Revenue/Employee

    1 k

    Financial Leverage

    1.1 x
    Show all financial metrics

    Reneuron Group Market Value History

    Reneuron Group's Web-traffic and Trends

    Reneuron Group Company Life and Culture

    You may also be interested in